{"title":"Detection of Lethal Dose 50 of Biofilm-producing Methicillin-resistant Staphylococcus aureus Local Isolate From Mastitis","authors":"A. A. Sheehan, Mohammed H. Khudor, F. Isihak","doi":"10.37940/ajvs.2021.14.2.3","DOIUrl":null,"url":null,"abstract":"It is very important, before starting the manufacture of any vaccine from any microorganism estimation of LD₅₀ of that microorganism to determine their pathogenicity and virulence. Estimated LD₅₀ was very important to be used in challenge tests later to estimate the protection level of the manufactured vaccine in experimental animals. So, this study was aimed to estimate LD₅₀ of local methicillin-resistant Staphylococcus aureus (MRSA) bacterial isolate. A pilot study has been done to determine approximately LD₅₀ of used MRSA in the study by using different bacterial concentrations of MRSA to determine approximate LD₅₀ that can be able to kill half numbers of animals used in the study to be used later in the estimation of exact LD₅₀ by using of Up-and-Down method. Ninety Wistar albino rats have been used for this purpose, eighty-four animals which divided into fourteen groups by six animals for each group (for pilot study) and remained six animals for (Up-and-Down method). The results showed that 9 X 10¹⁰ CFU/ml was led to killing half number of animals used in the study, this dose has been used as starting dose in the Up-and-Down method to the estimation of the exact LD₅₀ dose. The results showed that 5.526 X 10¹⁰ CFU/ml was the exact LD₅₀ of local MRSA isolate, which will be used later in the challenge test to estimate the protection level of a locally prepared vaccine against MRSA isolate.","PeriodicalId":52734,"journal":{"name":"mjl@ lnbr ll`lwm lbyTry@","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"mjl@ lnbr ll`lwm lbyTry@","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.37940/ajvs.2021.14.2.3","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
It is very important, before starting the manufacture of any vaccine from any microorganism estimation of LD₅₀ of that microorganism to determine their pathogenicity and virulence. Estimated LD₅₀ was very important to be used in challenge tests later to estimate the protection level of the manufactured vaccine in experimental animals. So, this study was aimed to estimate LD₅₀ of local methicillin-resistant Staphylococcus aureus (MRSA) bacterial isolate. A pilot study has been done to determine approximately LD₅₀ of used MRSA in the study by using different bacterial concentrations of MRSA to determine approximate LD₅₀ that can be able to kill half numbers of animals used in the study to be used later in the estimation of exact LD₅₀ by using of Up-and-Down method. Ninety Wistar albino rats have been used for this purpose, eighty-four animals which divided into fourteen groups by six animals for each group (for pilot study) and remained six animals for (Up-and-Down method). The results showed that 9 X 10¹⁰ CFU/ml was led to killing half number of animals used in the study, this dose has been used as starting dose in the Up-and-Down method to the estimation of the exact LD₅₀ dose. The results showed that 5.526 X 10¹⁰ CFU/ml was the exact LD₅₀ of local MRSA isolate, which will be used later in the challenge test to estimate the protection level of a locally prepared vaccine against MRSA isolate.
在开始从任何微生物生产任何疫苗之前,对该微生物的LD₅0进行估算,以确定其致病性和毒力,这一点非常重要。估计的LD₅0非常重要,可用于随后的挑战测试,以估计制造的疫苗在实验动物中的保护水平。因此,本研究旨在估计当地耐甲氧西林金黄色葡萄球菌(MRSA)细菌分离物的LD₅0。已经进行了一项试点研究,通过使用MRSA的不同细菌浓度来确定研究中使用的MRSA的大约LD₅0,以确定大约LD₅0,该₅0可以杀死研究中使用的动物的一半数量,以便稍后使用上下法来估计精确的LD₅0。90只Wistar白化大鼠,84只动物,分为14组,每组6只动物(初步研究),其余6只动物(上下法)。结果表明,9 X 10¹⁰CFU/ml导致研究中使用的一半动物死亡,该剂量已被用作上下法中的起始剂量,以估计确切的LD₅₀剂量。结果表明,5.526 X 10¹CFU/ml是当地MRSA分离物的确切LD₅0,将在稍后的挑战测试中使用,以估计当地制备的疫苗对MRSA分离物的保护水平。